MDLN Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response FMNB Q1 2026 Earnings EPS Surges Past Estimates with 21 Beat Stock Edges Lower Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress ACRS Q1 2026 Earnings Narrower Loss Beats Estimates but Stock Dips on No Revenue Update CRVS Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Clinical Development Morgan Stanley Adjusts Palo Alto Networks Stock Price Target Amid Demand Trends RGEN Q1 2026 Earnings EPS Surges Past Estimates by 22 Revenue Details Not Disclosed